Charlotte Reinstates the Johnson & Johnson COVID-19 vaccine
May 14, 2021
An article by The Charlotte Observer titled "Charlotte Health Providers Resume Using Johnson & Johnson Vaccine Amid Hesitancy Concerns
" reports that Charlotte's major health providers have started administering the Johnson & Johnson vaccine after a two-week halt. Statements from health officials have not stopped the unease that this decision stirred in some parts of the county.
The Johnson & Johnson COVID-19 vaccine had been put on hold after six blood clots cases came out from among 6.8 million recipients. Now that the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration have lifted this pause, hospital systems and health care providers are carrying out plans to continue distributing the Johnson & Johnson vaccine to the Charlotte population.
Mecklenburg County Public Health will bring the Johnson & Johnson vaccine to homebound patients, and StarMed Healthcare plans on adding doses of the vaccine to its walk-in vaccination spot. When it comes to the county's hospital systems, Novant Health started administering the vaccine this week and plans on making the Pfizer and Moderna vaccines available in all events offering the Johnson & Johnson vaccine. While Atrium Health has yet to disclose a timeline, the information available also points toward the reintroduction of the Johnson & Johnson vaccine. "Ultimately, the decision was made that the greater protection to our community is provided by resuming use of the J&J vaccine," said Atrium Health in a statement.
Until recently, the Johnson & Johnson vaccine represented an important logistical asset, being the only vaccine available to provide immunity with a single shot. Reports from The Washington Post reveal that the warnings issued during the past weeks have made people wary, with 73% of participants not being comfortable taking the Johnson & Johnson vaccine.
You can read the complete article here: Charlotte Health Providers Resume Using Johnson & Johnson Vaccine Amid Hesitancy Concerns